New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
09:15 EDTDKS, ECYT, LIVE, IRDM, CLVS, DNDN, NVS, OPHT, GPK, CCL, ACXM, TJX, ARX, URBN, ICPT, ODP, SPLS, CAB, MRKOn The Fly: Pre-market Movers
HIGHER: Aeroflex (ARX), up 25% after agreeing to be acquired by Cobham for about $1.46B... Clovis (CLVS), up 6.6% after receiving breakthrough therapy designation for CO-1686... Ophthotech (OPHT), up 17.6% after entering into an ex-U.S. licensing, commercialization agreement with Novartis (NVS) for Fovista... Dendreon (DNDN), up 9% after announcing presentation of PROVENGE ProACT, IMPACT studies data... Iridium (IRDM), up 5% after upgraded at Raymond James... Acxiom (ACXM), up 3% after upgraded at Wells Fargo... Carnival (CCL), up 2% following upgrade at Morgan Stanley. DOWN AFTER EARNINGS: Dick's Sporting (DKS), down 15%. Peer Cabelas (CAB) also down 2% after Dick's report... Staples (SPLS), down 10%. Peer Office Depot (ODP) also down 2.6% after Staples' report... Urban Outfitters (URBN), down 4%... TJX (TJX), down 4.7%. ALSO LOWER: Intercept (ICPT), down 5.8% after The Street reported that the company knew of abnormal cholesterol levels in patients taking its liver disease drug obeticholic acid... Graphic Packaging (GPK), down 3% after offering 43.65M shares of common stock for holders... LiveDeal (LIVE), down 15% after entering 10M share common stock distribution agreement... Endocyte (ECYT), down 5% after company and partner Merck (MRK) withdraw CMA for vintafolide in Europe.... Molycorp (MCP), down 2.5% after downgraded at Morgan Stanley.
News For DKS;CAB;SPLS;ODP;ICPT;URBN;ARX;TJX;ACXM;CCL;GPK;OPHT;NVS;DNDN;CLVS;IRDM;LIVE;ECYT;MRK From The Last 14 Days
Check below for free stories on DKS;CAB;SPLS;ODP;ICPT;URBN;ARX;TJX;ACXM;CCL;GPK;OPHT;NVS;DNDN;CLVS;IRDM;LIVE;ECYT;MRK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
August 11, 2014
17:11 EDTICPTIntercept says 46% of OCA group met FLINT endpoint vs. 21% for placebo group
Subscribe for More Information
16:24 EDTICPTIntercept reports Q2 EPS $1.51, may not compare to consensus (12c)
Subscribe for More Information
15:32 EDTICPTNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Ventas (VTR), consensus $1.09; Nuance Communications (NUAN), consensus 27c; Intercept Pharmaceuticals (ICPT), consensus (12c); Rackspace Hosting (RAX), consensus 16c; Opko Health (OPK), consensus (9c); Mindray Medical (MR), consensus 54c; Chimera Investment (CIM), consensus 9c; Globalstar (GSAT), one estimate (4c); 51job (JOBS), consensus 32c; Dealertrack Technologies (TRAK), consensus 373c; Caesars Entertainment (CZR), consensus ($1.19); Towerstream (TWER), consensus (10c); Resolute Energy (REN), consensus 1c; Forest Oil (FST), consensus (2c).
10:13 EDTTJXTJX volatility flat into Q2 and outlook
Subscribe for More Information
06:52 EDTDKSDick's Sporting still has a downward bias to estimates, says RBC Capital
Subscribe for More Information
05:18 EDTNVSNovartis reports LCZ696 significantly reduced cardiovascular deaths
New data revealing the reduction in cardiovascular, or CV, deaths with Novartis' LCZ696 in patients with heart failure with reduced ejection fraction, or HF-REF, will be presented at the European Society of Cardiology, or ESC, Congress 2014. The 8,442 patient study, PARADIGM-HF, was specifically designed to see if LCZ696 could increase survival over and above what can be achieved with ACE-inhibitor enalapril in addition to current best treatment in HF-REF patients. In March the Data Monitoring Committee overseeing the study confirmed those given LCZ696 were significantly less likely to die from CV causes, leading to the trial being closed early. LCZ696 significantly reduced cardiovascular deaths in head to head study against enalapril, in addition to current best treatment, in patients with HF-REF. PARADIGM-HF is the largest heart failure study ever conducted and was stopped early in March due to compelling efficacy. LCZ696 was recently granted FDA Fast Track status and rolling submission expected to be complete by end of year.
August 8, 2014
12:12 EDTDKSDick's Sporting volatility elevated into Q2 and outlook
Subscribe for More Information
10:36 EDTDKSOptions with increasing implied volatility
Subscribe for More Information
10:16 EDTDKSHigh option volume stocks
High option volume stocks: TKMR JOE HMSY TDC XOMA XPO VGK DKS BCOR DRTX
06:51 EDTNVSJudge rules DOJ can pursue Novartis kickback suit, Reuters says
U.S. District Judge Colleen McMahon ruled that the U.S. Department of Justice is allowed to continue its False Claims Act lawsuit versus Novartis regarding allegations that the company used kickbacks to increase sales of medications covered by Medicare and Medicaid, according to Reuters, citing comments from McMahon. Reference Link
06:44 EDTCLVSClovis October volatility elevated into updates
Subscribe for More Information
06:39 EDTCLVSClovis price target raised to $100 from $87 at Piper Jaffray
Piper Jaffray raised its price target for Clovis shares to $100 saying the company's clinical development programs are progressing well, with strong enrollment indicated for rociletinib and rucaparib trials. Piper reiterates an Overweight rating on the stock.
06:34 EDTICPTIntercept volatility elevated into data
Intercept overall option implied volatility of 106 is above its 26-week average of 97 according to Track Data, suggesting large price movement into the expected release of Phase 2b FLINT 72 week data.
August 7, 2014
10:00 EDTCCLOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:38 EDTNVSEnanta's HCV NS5A inhibitor EDP-239 advances into combination studies
Subscribe for More Information
07:45 EDTCCLCarnival upgraded at BofA/Merrill
Subscribe for More Information
06:21 EDTCCLCarnival upgraded to Buy from Neutral at BofA/Merrill
Subscribe for More Information
August 6, 2014
11:36 EDTACXMAcxiom signs global agreement with ACE Group
Subscribe for More Information
07:48 EDTGPKHighway bill could boost IP, RockTenn shares, says Jefferies
Jefferies notes the Senate and House agreed last week on the highway bill, which allows corporations to push out pension contributions. The firm thinks the bill will accelerate free cash flow generation for International Paper (IP), RockTenn (RKT) and Sonoco (SON). Jefferies believes shares of International Paper and RockTenn could move higher since the paper names are mainly valued on free cash flow. The firm does not expect much pension relief from the bill for Owens-Illinois (OI), Crown Holdings (CCK) and Graphic Packaging (GPK).
06:32 EDTOPHTOphthotech reports Q2 EPS ($1.57), consensus (56c)
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use